Heart Failure & COPD Case Study: Interventions & Medications
This case study examines the clinical presentation and management of a patient admitted with acute decompensated heart failure and an acute exacerbation of chronic obstructive pulmonary disease (COPD). The paper identifies four cardiovascular conditions the patient is at risk for — hypertension, atrial fibrillation, coronary artery disease, and chronic kidney disease — and outlines appropriate pharmacological and lifestyle interventions for each. It then evaluates the patient's admission medication regimen, including furosemide, enalapril, metoprolol, IV morphine, and inhaled bronchodilators, and proposes supplementary interventions such as statin therapy, anticoagulation, and dietary support. Finally, the paper discusses nursing strategies to prevent drug interactions, including medication reconciliation and patient education.
- Clinical Manifestations: Subjective and objective patient presentation on admission
- Four Cardiovascular Conditions and Interventions: Hypertension, AFib, CAD, and CKD risk management
- Intervention Analysis: Evaluation of admission treatments and proposed additions
- Medication Explanation: Drug classes, mechanisms, and rationale for each medication
- Nursing Interventions for Drug Interactions: Reconciliation, education, and monitoring to prevent interactions
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper moves logically from assessment (clinical manifestations) to diagnosis (cardiovascular risk conditions) to treatment (medications) to nursing management, mirroring the clinical reasoning process nurses use in practice.
- Each medication is identified by class as well as name, and its rationale is explicitly tied to the patient's specific presenting symptoms, strengthening the clinical justification for each choice.
- The intervention analysis section goes beyond describing current treatment to propose future refinements — statin therapy, anticoagulation, and dietitian referral — demonstrating evaluative, not just descriptive, thinking.
Key academic technique demonstrated
The paper demonstrates evidence-based clinical reasoning: every major pharmacological choice is supported by a peer-reviewed citation, showing how academic literature grounds bedside decision-making. This technique — linking each intervention to a source — is essential in nursing and health sciences writing and signals graduate-level professional practice.
Structure breakdown
The paper opens with a subjective/objective clinical snapshot, then catalogues four cardiovascular risk conditions with preventive strategies. An intervention analysis evaluates admission treatments and recommends additions. A dedicated medication section explains each drug's class and mechanism. The paper closes with nursing-specific strategies — medication reconciliation and patient education — to prevent drug interactions. Five APA-formatted references anchor the clinical claims.
Clinical Manifestations
Subjectively, the patient presented with anxiety (she was worried her health was so bad she was going to die), difficulty breathing, exhaustion, and a lack of strength to eat or drink. Objectively, she had an irregular heartbeat, elevated heart rate, low blood pressure, crackles in her lungs, hepatomegaly, and blood-tinged sputum. She also had fever and malaise, which could be symptoms of an acute decompensation of her chronic conditions triggered by an acute infection (Caterino et al., 2019).
Four Cardiovascular Conditions and Interventions
The cardiovascular conditions this patient is at risk for include hypertension, atrial fibrillation, coronary artery disease, and chronic kidney disease.
Uncontrolled hypertension can lead to left ventricular hypertrophy and ultimately heart failure (Slivnick & Lampert, 2019). Antihypertensive drugs such as enalapril can be administered, along with lifestyle modifications such as dietary changes and exercise.
Atrial fibrillation can cause heart failure due to a rapid heart rate and inefficient cardiac filling. Rate or rhythm control strategies can be adopted to prevent this and would include using beta-blockers such as metoprolol (Watson et al., 2022).
Additionally, prolonged hypertension and smoking can lead to coronary artery disease. Statins and antiplatelet agents can be used for prevention.
Hypertension and diabetes can also be contributing factors to chronic kidney disease, which can cause fluid overload and heart failure. Blood pressure control, ACE inhibitors, and good glycemic control can help manage this risk.
Intervention Analysis
When evaluating the patient's interventions upon admission, it is clear they were fundamentally beneficial, as they tackled her immediate life-threatening conditions. These included acute decompensated heart failure and an acute exacerbation of her chronic obstructive pulmonary disease (COPD). The administration of drugs such as furosemide, enalapril, metoprolol, and bronchodilators, among others, aimed to manage her fluid overload, hypertension, irregular heart rate, and respiratory distress — all urgent needs for her stability.
Nevertheless, in terms of future changes, a more comprehensive approach could be considered to address her other existing risk factors and prevent potential complications. For instance, starting her on a statin may be wise for the long-term management of potential coronary artery disease, given her long history of smoking and hypertension. Statins are cholesterol-lowering drugs that can help prevent the build-up of plaque in the arteries, thereby reducing the risk of heart attacks and strokes.
Furthermore, considering the patient's presentation of atrial fibrillation, initiating anticoagulation therapy could be beneficial in preventing potential strokes. Atrial fibrillation increases the risk of blood clot formation in the heart; these clots can travel to the brain and cause a stroke.
Lastly, since the patient presents with difficulty performing activities of daily living (ADLs) and likely has nutritional challenges, a referral to a dietitian could aid in providing tailored nutritional support and advice on weight management. This could promote her overall wellbeing and potentially reduce the burden of her chronic conditions.
References
Caterino, J. M., Kline, D. M., Leininger, R., Southerland, L. T., Carpenter, C. R., Baugh, C. W., ... & Stevenson, K. B. (2019). Nonspecific symptoms lack diagnostic accuracy for infection in older patients in the emergency department. Journal of the American Geriatrics Society, 67(3), 484–492.
Cerón-Pisa, N., Shafiek, H., Martín-Medina, A., Verdú, J., Jordana-Lluch, E., Escobar-Salom, M., ... & Cosío, B. G. (2022). Effects of inhaled corticosteroids on the innate immunological response to Pseudomonas aeruginosa infection in patients with COPD. International Journal of Molecular Sciences, 23(15), 8127.
Seo, Y., Lee, H. J., Ha, E. J., & Ha, T. S. (2022). 2021 KSCCM clinical practice guidelines for pain, agitation, delirium, immobility, and sleep disturbance in the intensive care unit. Acute and Critical Care, 37(1), 1–25.
Slivnick, J., & Lampert, B. C. (2019). Hypertension and heart failure. Heart Failure Clinics, 15(4), 531–541.
Watson, M. P., Bennett, M., Hamilton, C., Hill, L., & McNally, O. (2022). Rate vs rhythm: Beta-blockers and antiarrhythmics as pharmacological options for the treatment of postoperative atrial fibrillation. British Journal of Cardiac Nursing, 17(11), 1–7.
Yang, T., Mei, X., Tackie-Yarboi, E., Akere, M. T., Kyoung, J., Mell, B., ... & Joe, B. (2022). Identification of a gut commensal that compromises the blood pressure-lowering effect of ester angiotensin-converting enzyme inhibitors. Hypertension, 79(8), 1591–1601.
Always verify citation format against your institution’s current style guide requirements.